History does not repeat but it rhymes: Indian equities are likely to display the same rhythm that the US and Nikkei did in 1990-2000 and 1980-1990, respectively, i.e. delivering a decadal move of 5x on headline indices. Our prognosis of various Technical studies leads us to the conclusion that the Nifty is poised to reach towards 50000 by CY30. More so, the performance of 2021 and 2022 further adds strength to our argument given the Nifty is mimicking our forecast trajectory. What is more exciting is that we are entering 2023, which, as per decadal studies, has turned out to be a strong year

The chemical industry’s growth is not hostage to any one economic parameter or any one end-user industry. Rising domestic demand and the need to evolve have forced domestic chemical companies to expand their capacities to remain competitive. Our positive stance on the sector is backed by its strong growth, aided by diversity in terms of chemistries and/or technologies

SMIFS has recommended four stocks to buy with good risk-reward ratios.

Bullish momentum which spilled over from October series in the form of short covering was held intact as bulls were unperturbed by any worries on global front. November series also witnessed fresh All time highs being registered on a closing basis. Bullish sentiments were distinctly visible as participants were confident of rolling over their bullish bets which was evident in high roll cost in Nifty. Last time Nifty had witnessed such a high roll cost was way back in September’20 series.

To Sum it up, Lower stock Futures’ Open Interest (compared to all time highs), Lower Open Interest in the Nifty Futures’ as compared to last 17 year average OI of 2.08 Cr shares despite Nifty near all time highs, FIIS long to short ratio in the Index Futures at 3.28 (Aggressive Long build up by FIIS in the Index Futures segment), aggressive Put writing at 18000 levels and strong recovery in the global markets from the recent lows indicates that downside is limited in the Nifty and one should remain optimistic for the December series also.

With capex cycle revival under way domestically and increasing acceptance of India as a credible, quality driven manufacturing hub (export opportunity), we stay constructive on overall markets. We believe any dips should be used to build a long term portfolio of quality companies that have lean balance sheets, are capital efficient in nature and possess growth longevity

The Navy’s big projects in pipeline give a longer term visibility to defence shipyard companies like Mazagon Dock, Cochin Shipyard and Garden Reach. Moreover, the need of new aircraft for INS Vikrant like twin engine deck based fighter (TEDBF) to be manufactured by HAL. With these new high tech aircraft & warships, players like Bharat Electronics & Data Patterns will also benefit significantly in the future.

Companies like BDL (CMP INR 988, Mcap INR 18,105 cr) , HAL (CMP INR 2501, Mcap 83,640 cr) and BEL ( CMP INR 108, Mcap INR 78,836 cr) among PSU’s and PTC Industries (CMP INR 2859, Mcap INR 3,745 cr), Paras Defense (CMP INR 639, Mcap INR 2,490 cr), Data Patterns (CMP INR 1335, Mcap INR 6,930 cr) and SOLAR industries (CMP INR 3935, Mcap INR 35,611 cr) among private companies are better placed to exploit the upcoming opportunity

Given the scenario, we see reasonable opportunities across the market spectrum with key filter being quality. We continueto advise investors to utilise equities as a key asset class for long term wealth generation by investing in quality companieswith strong earnings growth and visibility, stable cash flows, RoE and RoCE.

We estimate our specialty chemical coverage universe revenue to grow 19.3% YoY (down 0.6% QoQ) in Q2FY23, partly on rise in prices due to input cost inflation. Gross profit to grow 22.7% YoY (down 1.4% QoQ, largely due to seasonality), which indicates strong underlying trend led by our expectation of 1) SRF’s robust growth (36.7% YoY) on continuous good show in ref-gas, offset by weakness in non-chemicals business